StockTipsArenaBeta

BUY Artemis Medicare Services Limited — Choice Broking

BUYArtemis Medicare Services Limited
Artemis Medicare Services share price target & all analyst calls

byChoice BrokingHorizon: 1 year23 Jun 2026via Economic Times New Stock Recos

Entry₹266.4Inferred
Target₹325
Total upside +22.00% (call closed)
Stop lossNot given
Exit₹32510 Aug 2026, 12:08 pm
Target hit+22.00%0.00%upside left
Follow Choice Broking for new calls(100% target hit, 20 closed calls)Get alertsWatch ARTEMISMED for new buy/sell callsGet alertsSee 1 active Long-term call on ARTEMISMEDSee 234 active Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 10 Aug 2026
6 supporting4 neutral0 opposing
Supports the BUY call (6)

1 advisor has an active short-term BUY call on this stock, issued in the last 14 days

Advisor consensus · adjacent horizon·6 Aug · 4d ago

Artemis Medicare Services Limited reported a 12.7% YoY increase in consolidated revenue for Q1 FY27, with EBITDA up 27.9% and profit up 48.3%.

NSE · Press Release·3 Aug · 6d ago

(opens in new tab)

Artemis Medicare Services Ltd announced its Q1 FY27 financial results, showing a 12.7% YoY increase in consolidated revenue to Rs 28,732 Lacs. EBITDA grew by 27.9% to Rs 6,182 Lacs, and PAT increased

BSE · Company Update·3 Aug · 6d ago

(opens in new tab)

1 other SEBI-registered advisor has an active long-term BUY call on this stock

Advisor consensus · same horizon·11 May · 3mo ago

Neutral / worth noting (4)

Artemis Medicare Services Limited announced its un-audited financial results for the quarter ended June 30, 2026, and an expansion plan for Tower IV at its flagship hospital in Gurugram.

NSE · Outcome of Board Meeting·3 Aug · 6d ago

(opens in new tab)

Artemis Medicare Services Ltd announced the outcome of its Board Meeting held on August 3, 2026. The board approved the un-audited financial results for the quarter ended June 30, 2026, and an expansi

BSE · Board Meeting·3 Aug · 6d ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Artemis Medicare Services

All analyst calls on Artemis Medicare Services

More from Choice Broking

Every call and its outcome